First-in-Man Dose-Escalation Study of the Selective BRAF Inhibitor RG7256 in Patients with BRAF V600-Mutated Advanced Solid Tumors.Published in:2016By:Dienstmann, Rodrigo;Lassen, Ulrik;Cebon, Jonathan;Desai, Jayesh;Brown, Michael;Evers, Stefan;Su, Fei;Zhang, Weijiang;Boisserie, Frederic;Lestini, Brian;Schostack, Kathleen;Meresse, Valerie;Tabernero, Josep;Brown, Michael PPublication type:journal article